| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $572.4M | +16.4% |
| Cost of Revenue | $223.8M | +15.9% |
| Gross Profit | $348.6M | +16.8% |
| R&D Expense | $58.2M | +39.0% |
| SG&A Expense | $145.9M | +20.0% |
| Operating Income | -$17.5M | -116.7% |
| Pre-tax Income | -$21.7M | -114.0% |
| Income Tax | -$8.6M | -494.7% |
| Net Income | -$13.1M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $68.2M | -25.7% |
| Accounts Receivable | $141.8M | +37.8% |
| Current Assets | $266.6M | +10.5% |
| Total Assets | $759.9M | +5.7% |
| Current Liabilities | $440.8M | +9.3% |
| Long-term Debt | $46.6M | -99.9% |
| Total Liabilities | $506.9M | +3.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $74.3M | -3.3% |
| Capital Expenditures | $49.3M | -15.8% |
| Investing Cash Flow | -$66.2M | +22.2% |
| Financing Cash Flow | -$26.5M | -254.9% |
| Free Cash Flow | $25.1M | +36.9% |
| -6.4% |
| Stockholders' Equity |
| $253.0M |
| +10.1% |